Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Homo sapiens

ABSTRACT: Lactate-treated cancer-associated fibroblasts of pancreatic ductal adenocarcinoma

PROVIDER: PRJDB16020 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR483574.fastq.gz	Fastqsanger.gz
	DRR483575.fastq.gz	Fastqsanger.gz
	DRR483576.fastq.gz	Fastqsanger.gz
	DRR483577.fastq.gz	Fastqsanger.gz
	DRR483578.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Homo sapiens

Project description:RAD51B Harbors Germline Mutations Associated with Pancreatic Ductal Adenocarcinoma

| PRJNA737570 | ENA

Disease associated fibroblasts from various pancreatic disorders exhibit subtype specific genetic profile [miRNA]

Project description:Currently it is unknown whether activation of recruited or resident pancreatic fibroblasts, including pancreatic stellate cells activation, create a common “fibroblast-activated phenotype” indistinguishable from their associated-diseased microenvironment . Using a combination of microRNA and mRNA profiling of fibroblasts isolated from pancreatic ductal adenocarcinoma (PDAC), chronic pancreatitis (CP), periampullary cancer (PAT) and areas of histologically normal pancreas, followed by comprehensive validation, we show that activated fibroblasts derived from different pancreatic disease types are considerably distinct.

2020-07-14 | GSE123377 | GEO

Disease associated fibroblasts from various pancreatic disorders exhibit subtype specific genetic profile [RNA]

2020-07-14 | GSE123375 | GEO

Transcription profiling by array of cancer associated fibroblasts from pancreatic ductal adenocarcinoma in comparison to normal dermal fibroblasts

Project description:Pancreatic ductal adenocarcinoma (PDAC) is an aggressive tumor type with extremely high mortality (up to 92%) during 5 years after diagnosis. Here, cancer associated fibroblasts (CAF) from PDAC were compared to CAF from melanoma metastases (MELF) and to normal dermal fibroblasts (DF). The analysis was performed in three biological replicates for normal fibroblasts, eight biological replicates for PDAC CAF, and four biological replicates for melanoma CAF. Further technical replicates were used to improve data quality.

2021-11-01 | E-MTAB-8764 | biostudies-arrayexpress

Homo sapiens

Project description:Expression data from pancreatic ductal adenocarcinoma

| PRJNA350389 | ENA

Homo sapiens

Project description:Gene expression in pancreatic ductal adenocarcinoma

| PRJNA240283 | ENA

Homo sapiens

Project description:Genome Sequencing in Pancreatic Ductal Adenocarcinoma

| PRJNA171808 | ENA

Role of Macrophage migration inhibitory factor (MIF) in pancreatic stellate cells (PSCs)

Project description:The presence of activated pancreatic stellate cells (PSCs) in the pancreatic ductal adenocarcinoma (PDAC) microenvironment plays a significant role in cancer progression. Macrophage migration inhibitory factor (MIF) is overexpressed in PDAC tissues and expressed by both cancer and stromal cells. The expression status of MIF and its receptors in PDAC- associated fibroblasts or PSCs and its pathophysiological roles are yet to be elucidated. The next-generation sequencing technique was adapted to check the effect of MIF absence on the expression of other genes in mice (mPSCs).

2022-09-28 | E-MTAB-9392 | biostudies-arrayexpress

Schwann cell condition medium MS

Project description:The effects of Schwann cells on the neuro-stroma niche in pancreatic ductal adenocarcinoma (PDAC) remain to be explored. Here, single-cell RNA-sequencing and spatial transcriptome analysis of PDAC tissues reveals that Schwann cells induce malignant subtypes of tumour cells and cancer-associated fibroblasts. Mass Spectrometry (MS) were performed to detected the potential functional factors secreted by Schwann cells.

2023-06-27 | PXD042556 | Pride

Homo sapiens

Project description:Gene expression signatures associated with Perineural Invasion in pancreatic ductal adenocarcinoma

| PRJNA397069 | ENA